STSSW SkyAI, Inc.

NEUTRAL Impact: 4/10 8-K
Horizon weeks Filed Jun 1, 2026 Processed 11d 20h ago SEC 0001493152-26-026534
8-K context-dependent: Items 8.01
Latest settled — T+5d
STSSW ▲ 0.00% at T+5d
NEUTRAL call ✗ call lost 0.00% · α vs SPY +2.75% · entry $0.0329 → $0.0329
Next anchor: T+20d in 17d
Currently $0.0329 · +0.00% from $0.0329 entry
Entry anchored
May 27, 10:46 AM ET
via Databento tick
T+1d
0.00%
call 0.00% · α -0.14%
$0.0329
settled 11d ago
T+5d
0.00%
call 0.00% · α +2.75%
$0.0329
settled 5d ago
T+20d
call — · α —
in 17d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

SkyAI, Inc. (formerly Sharps Technology, Inc.) filed an 8-K announcing a name change to SkyAI, Inc., new ticker symbols (SKYA for common, SKYAW for warrants), and a strategic pivot from its legacy medical device business to building an 'agentic finance platform' targeting emerging markets. The company has opened a Hong Kong headquarters and plans to use Solana blockchain and AI to offer stablecoin-based financial services. No financial data, revenue figures, or deal values were disclosed.

Actionable Insight

This is a narrative-driven rebranding and pivot from a legacy medical device company to a fintech/AI story. With no financials or guidance provided, the stock may trade on sentiment and the credibility of the new management team's execution. Monitor for subsequent announcements detailing the platform, partnerships, or any capital raise to fund this transformation.

Key Facts

  • Company changed name from Sharps Technology, Inc. to SkyAI, Inc. effective May 26, 2026.
  • Common stock ticker changed from STSS to SKYA; warrants from STSSW to SKYAW, effective May 28, 2026.
  • Company is pivoting from legacy medical device operations to building an 'agentic finance platform' for the Global South (Asia, Latin America, Africa).
  • Company opened an operational headquarters in Hong Kong for licensing and talent acquisition.
  • Platform will leverage Solana blockchain and AI to provide stablecoin-based savings, financial education, and data-driven insights.
  • No financial figures, revenue, earnings, guidance, or deal values were provided in the filing.
  • The filing includes extensive risk factor disclosures about AI technology, regulatory uncertainty, and digital asset volatility.

Financial Impact

No financial figures disclosed. The filing is a strategic rebranding and business model pivot with no quantifiable financial impact reported.

Risk Factors

  • No revenue or financial data disclosed — the pivot is entirely pre-revenue and speculative.
  • Extensive risk factors highlight AI regulatory uncertainty, blockchain volatility, and execution risk in emerging markets.
  • The company is an emerging growth company with no demonstrated track record in fintech or AI.
  • Potential for significant dilution if the company raises capital to fund the new strategy.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001493152-26-026534
Exhibit: ex99-1.htm0001493152-26-026534
Exhibit: ex3-1.htm0001493152-26-026534
Document: 0001493152-26-026534-index-headers.html0001493152-26-026534
Document: 0001493152-26-026534-index.html0001493152-26-026534
Document: 0001493152-26-026534.txt0001493152-26-026534
2 reports for STSSW
Performance horizon
Filters
Rows
Reports for STSSW — sortable, filterable
Type Now
Jun 1, 2026
11d ago
8-K
NEUTRAL ★ 4/10
$0.0329 $0.0329· 0.00%▲ +2.75%$0.0329 (+0.00%)
May 29, 2026
14d ago
8-K
NEUTRAL ★ 2/10
$0.0329 $0.0329· 0.00%▲ +2.75%$0.0329 (+0.00%)
Showing 2 of 2

US Market Status

Market Closed — Opens Mon (53h 12m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access